You go in for a routine abdominal ultrasound or a checkup, and the report comes back noting "hepatic steatosis" or "fatty liver." Your primary care doctor may have mentioned it briefly, or the note may have arrived in your patient portal with little explanation. This is a very common scenario, and it leaves many patients in Brooklyn unsure of what to do next.
Fatty liver disease is not a single condition. It is a spectrum, and where you fall on that spectrum determines how urgent the conversation with a gastroenterologist needs to be. Here is what you actually need to know.
What Fatty Liver Disease Actually Is
Your liver naturally processes and stores a small amount of fat. Problems begin when fat makes up more than roughly five percent of the liver's weight. When that buildup is not caused by heavy alcohol use, it is called metabolic dysfunction-associated steatotic liver disease, or MASLD. You may see older terms like nonalcoholic fatty liver disease (NAFLD) in reports from a few years ago. They refer to the same condition.
There is also a more aggressive form called metabolic dysfunction-associated steatohepatitis, or MASH (formerly NASH). In MASH, the liver is not just storing excess fat. It is actively inflamed. That inflammation causes ongoing cell damage, and over time, that damage creates scar tissue.
The key distinction:
- Simple fatty liver (steatosis): fat is present but the liver is not significantly inflamed; progression is slow in most people
- MASH: fat plus inflammation plus ballooning of liver cells; carries meaningful risk of progressing to fibrosis and cirrhosis
- Fibrosis and cirrhosis: scarring that impairs liver function; at advanced stages, it cannot be reversed
A report saying "fatty liver" does not tell you which stage you are at. That requires further evaluation.
Who Is at Risk, and How Common Is This in Brooklyn
Fatty liver disease has become one of the most prevalent liver conditions in the United States. Conditions that strongly raise your risk include:
- Type 2 diabetes or insulin resistance
- Obesity, particularly excess weight carried around the abdomen
- High triglycerides or low HDL cholesterol
- High blood pressure
- Metabolic syndrome
- Rapid weight loss or poor nutritional intake
Residents of neighborhoods like Sunset Park, Bay Ridge, Bensonhurst, Borough Park, and Dyker Heights include large populations of Chinese-American, Hispanic, and South Asian patients. Research has shown that people of East Asian and South Asian descent can develop significant liver fat at lower body weight thresholds than those established for European populations. If you have been told you have fatty liver and your weight seems normal, that finding is still worth taking seriously.
Fatty liver disease is also common in people with Hepatitis B, which is disproportionately prevalent in communities with roots in East Asia and Southeast Asia. The interaction between chronic Hepatitis B and metabolic-related fat accumulation requires careful monitoring, because the risk calculus is different from patients who have only one of the two conditions.
Why Fatty Liver Is Easy to Miss and Easy to Ignore
Most people with simple fatty liver have no symptoms. The liver does not have pain receptors the way your muscles do. By the time symptoms appear, such as fatigue, mild right-side abdominal discomfort, or a general feeling of illness, the disease has often progressed significantly.
Because the early stages cause no pain and limited disruption to daily life, patients sometimes receive a diagnosis of fatty liver and then wait years before following up. During that time, inflammation can silently continue. Routine liver enzyme tests (ALT, AST) can be normal even in the presence of significant liver disease, which gives patients and providers a false sense that no action is needed.
This is exactly why a diagnosis of fatty liver on an imaging report, even one framed as mild or incidental, warrants a proper evaluation rather than a watch-and-wait approach without guidance.
What Happens If Fatty Liver Goes Unaddressed
For many people with simple steatosis and no other risk factors, the condition does not progress significantly if metabolic risk factors are managed. But a meaningful subset of patients does progress, and there is currently no reliable way to predict exactly who will advance to MASH and fibrosis without specific testing.
Advanced fibrosis and cirrhosis carry serious consequences:
- Impaired liver function, including reduced ability to clear toxins and produce proteins the body needs
- Portal hypertension, which can lead to varices (enlarged blood vessels prone to bleeding) and fluid accumulation in the abdomen
- Significantly elevated risk of liver cancer (hepatocellular carcinoma)
- In the most advanced cases, liver failure requiring evaluation for transplant
Liver cancer risk is not limited to patients who have already reached cirrhosis. Patients with MASH-related fibrosis at earlier stages also face elevated risk, which is why periodic surveillance is part of good liver disease management for the right patients.
On a more hopeful note: the liver has considerable capacity to recover. When fibrosis is caught before it becomes cirrhosis, meaningful reversal is possible with sustained lifestyle and metabolic improvements. Early evaluation gives you more options.
How Fatty Liver Is Properly Evaluated
An ultrasound report noting fatty change is a starting point, not a complete picture. A full evaluation typically involves:
- Detailed history: alcohol intake, medications, metabolic conditions, family history of liver disease, and recent weight changes
- Laboratory panels: liver enzymes, metabolic markers, and tests to rule out other causes of liver disease such as autoimmune hepatitis, iron overload (hemochromatosis), or Wilson's disease
- Non-invasive fibrosis assessment: tools such as the FIB-4 index (calculated from age, AST, ALT, and platelet count) can help estimate the likelihood of significant fibrosis without a biopsy
- Advanced imaging: elastography techniques, either ultrasound-based (FibroScan) or MRI-based, can measure liver stiffness as a proxy for scarring
- Liver biopsy: remains the most definitive way to stage disease, though it is typically reserved for cases where non-invasive methods leave important questions unanswered
The goal of evaluation is to determine your stage, your trajectory, and what interventions make sense for your specific situation. Not every patient needs a biopsy. But every patient with a fatty liver finding deserves more than a dismissal.
How Advanced Gastro-Intestinal Medical Associates Approaches Liver Disease Care
At Advanced Gastro-Intestinal Medical Associates in Brooklyn, Dr. Patrick Pei Ying Xiao and the clinical team provide comprehensive evaluation and management of liver conditions, including fatty liver disease at all stages. Dr. Xiao completed his fellowship in Gastroenterology and Hepatology at SUNY Downstate Health Sciences University and has contributed to clinical research in viral hepatitis therapies. His focus on hepatology means he understands both the metabolic drivers of fatty liver and the overlap with conditions like Hepatitis B, which is particularly relevant in the practice's patient population.
The practice addresses fatty liver disease as part of a broader liver disease program that includes Hepatitis B, Hepatitis C, alcoholic hepatitis, and cirrhosis management. Patients can be evaluated with appropriate laboratory and imaging workup, and those with more advanced disease are managed with evidence-based monitoring and treatment protocols.
For patients who also need upper endoscopy to evaluate complications of advanced liver disease, or who require coordination of care for related GI conditions, that evaluation happens within the same practice. Dr. Xiao personally performs all endoscopic procedures.
The office is located at 717 56th Street in Brooklyn's Sunset Park neighborhood, convenient to patients throughout Bay Ridge, Bensonhurst, Borough Park, and Dyker Heights. The practice accepts Medicare, Medicaid, and most major commercial insurance plans. Staff provide care in English, Mandarin, Cantonese, and Spanish, with interpreter services available for additional languages.
Frequently Asked Questions
I was told I have mild fatty liver. Do I actually need to see a gastroenterologist?
Yes, an evaluation is worth having. A gastroenterologist or hepatologist can assess your stage more precisely than imaging alone, identify whether other liver conditions are contributing, and give you a clear sense of your actual risk. Many patients with mild fatty liver do well with lifestyle changes, but those changes are more targeted when based on a proper workup. Waiting years without follow-up is how some patients reach advanced fibrosis without realizing the disease was progressing.
My liver enzymes are normal. Does that mean my fatty liver is not a concern?
Normal ALT and AST levels do not rule out significant fatty liver disease. Studies have consistently shown that patients with normal or near-normal enzyme levels can have meaningful fibrosis on biopsy. Liver enzymes reflect active inflammation at the time of the blood draw, not the cumulative damage already done. A normal enzyme result should not be the reason you skip an evaluation if you have other risk factors or imaging findings.
Can fatty liver actually be reversed?
Simple steatosis and even early fibrosis can improve with sustained metabolic changes, including weight loss, improved blood sugar control, and in some cases, management of underlying conditions like hyperlipidemia. The liver does regenerate, and patients who achieve meaningful weight reduction often see measurable improvements in both liver fat and stiffness. The earlier the disease is caught, the more room there is to improve. Advanced cirrhosis, by contrast, involves permanent structural damage that cannot fully reverse. This is why timing matters.
Where is Advanced Gastro-Intestinal Medical Associates located, and how do I schedule an appointment?
The practice is located at 717 56th Street, Brooklyn, NY 11220, in the Sunset Park neighborhood, with convenient access for patients from Bay Ridge, Bensonhurst, Borough Park, and Dyker Heights. You can reach the office by phone at (718) 435-3890 to schedule an appointment or request a consultation. The practice accepts new patients and offers telehealth visits for eligible patients. Office hours run Monday through Thursday and Sunday.